封面
市场调查报告书
商品编码
1747600

分子细胞遗传学市场(按产品类型、技术、应用和地区划分)

Molecular Cytogenetics Market, By Product Type, By Technology, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

分子细胞遗传学市场规模预计在 2025 年为 65.272 亿美元,预计到 2032 年将达到 302.63 亿美元,2025 年至 2032 年的复合年增长率为 24.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 65.272亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 24.50% 2032年价值预测 302.63亿美元

分子细胞遗传学是分子生物学和细胞遗传学的结合。分子细胞遗传学涵盖染色体生物学的各个方面,在疾病诊断和染色体异常方面有着广泛的应用。分子细胞遗传学可以区分正常细胞和癌细胞。在分子细胞遗传学中,会使用萤光原位杂交 (FISH) 等技术,其中 DNA 探针以不同颜色的萤光标籤标记,以可视化整个萤光或基因组中最特异性的区域。分子细胞杂合反应有助于研究染色体及其细胞核的结构和功能组织、基因组突变、表现和演化,以及医学和癌症相关遗传学中的染色体异常。癌症的高发生率以及分子生物学在检测与癌症市场发展相关的遗传易感性方面的应用日益广泛,预计将推动全球分子细胞遗传学市场的成长。

市场动态

为了透过在产品系列中添加先进的 PSS 硬体、软体、色谱柱和标准来加强和确保提供广泛的产品(例如 LC 仪器、GPC/SEC 分析),主要市场参与企业正专注于采用收购等成长策略,这有助于全球分子细胞遗传学市场的成长。例如,2022 年 8 月,仪器、软体和服务供应商安捷伦科技公司宣布已收购聚合物表征领域的解决方案供应商Polymer Standards Service GmbH (PSS)。 PSS 专门提供用于定义和创建分子结构的硬体和软体解决方案。该公司提供凝胶渗透层析法(GPC) 和尺寸排阻层析法(SEC) 的完整解决方案,用于测量聚合物的分子量和尺寸分布。

本研究的主要特点

  • 本报告对全球分子细胞遗传学市场进行了详细分析,并以 2024 年为基准年,提供了 2025 年至 2032 年预测期的市场规模和年复合成长率(CAGR)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球分子细胞遗传学市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球分子细胞遗传学市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球分子细胞遗传学市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 限制因素
  • 市场机会
  • 影响分析
  • 最新产品发布
  • 流行病学
  • 合併、收购和合作
  • 监管情景
  • 主要进展
  • PEST分析

4. 2020 年至 2032 年全球分子细胞遗传学市场(依产品类型)

  • 装置
  • 耗材
  • 软体和服务

5. 全球分子细胞遗传学市场(依技术划分),2020 年至 2032 年

  • FISH
  • aCGH

6. 全球分子细胞遗传学市场(按应用划分),2020 年至 2032 年

  • 遗传性疾病
  • 癌症
  • 个人化医疗
  • 其他的

7. 全球分子细胞遗传学市场(按地区划分),2020 年至 2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第八章 竞争态势

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging, Inc.
  • BI Biological Industries
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific Inc.
  • CytoTest Inc.
  • Cytognomix, Inc.
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Bionano Genomics, Inc.
  • Precipio, Inc.
  • Leica Biosystems

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI2491

Molecular Cytogenetics Market is estimated to be valued at USD 6,527.2 Mn in 2025 and is expected to reach USD 30,263 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6,527.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 24.50% 2032 Value Projection: USD 30,263 Mn

Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of applications in disease diagnosis and chromosomal abnormalities. It enables to differentiate normal and cancer causing cells. In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome. Molecular cytogenetics helps to study the structural and functional organization of chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities in medicinal and cancer-related genetics. The high prevalence of cancer and increasing application of molecular biology in the detection of inherited susceptibilities associated with cancer development is expected to boost the global molecular cytogenetics market growth.

Market Dynamics

To add advanced PSS hardware, software, columns, and reference materials to the product portfolio which will enhance the offerings and ensure delivery of the broad spectrum of LC equipment, GPC/SEC analytics, the key market players are focusing on adoption of growth strategies such as acquisition which is attributed to the growth of global molecular cytogenetics market. For instance, in August 2022, Agilent Technologies Inc., provider of instruments, software, services, etc., announced it has acquired Polymer Standards Service GmbH (PSS) a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.

Key features of the study

  • This report provides an in-depth analysis of the global molecular cytogenetics market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global molecular cytogenetics market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global molecular cytogenetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular cytogenetics market

Market Segmentation

  • Global Molecular Cytogenetics Market, By Product Type
    • Instruments
    • Consumables
    • Software and Services
  • Global Molecular Cytogenetics Market, By Technology
    • FISH
    • aCGH
  • Global Molecular Cytogenetics Market, By Application
    • Genetic Disorders
    • Cancer
    • Personalized Medicine
    • Others
  • Global Molecular Cytogenetics Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Abbott Laboratories
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Applied Spectral Imaging, Inc.
    • BI Biological Industries
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific Inc.
    • CytoTest Inc.
    • Cytognomix, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Bionano Genomics, Inc.
    • Precipio, Inc.
    • Leica Biosystems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Molecular Cytogenetics Market, By Product Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Molecular Cytogenetics Market, By Technology, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • FISH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • aCGH
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Molecular Cytogenetics Market, By Application, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Genetic Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Molecular Cytogenetics Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2020- 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Affymetrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Applied Spectral Imaging, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BI Biological Industries
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CytoTest Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cytognomix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bionano Genomics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Precipio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leica Biosystems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us